Exponential Spread of Hepatitis C Virus Genotype 4a in Egypt

Journal of Molecular Evolution

Volumn 58, Issue 2, 2004, Pages 191-195

  Tanaka, Yasuhito ^a   Agha, Salah ^b   Saudy, Niveen ^b   Kurbanov, Fuat ^a   Orito, Etsuro ^a   Kato, Takanobu ^a   Abo Zeid, Mostafa ^b   Khalaf, Mohamed ^c   Miyakawa, Yuzo ^d   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b MANSOURA UNIVERSITY   (Egypt)

^c Assiut University Faculty of Medicine   (Egypt)

^d Miyakawa Memorial Research Foundation   (Japan)

Author keywords

Egypt; Genotype 4a; Hepatic C virus; Molecular evolutionary analyses; Neutral theory; Parenteral treatment; Schistosomiasis

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD ANALYSIS; EGYPT; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HUMAN; MALE; MOLECULAR EVOLUTION; NATIVE SPECIES; NEUTRAL GENE THEORY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; VIRAL GENETICS; VIRUS ISOLATION;

ADULT; ANTIMONY; BASE SEQUENCE; DATABASES, GENETIC; DNA, COMPLEMENTARY; EGYPT; EVOLUTION, MOLECULAR; FEMALE; GENETIC DRIFT; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IATROGENIC DISEASE; INFUSIONS, PARENTERAL; LIKELIHOOD FUNCTIONS; MALE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; SCHISTOSOMIASIS; SEQUENCE ANALYSIS, DNA;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 10744228243     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-003-2541-3     Document Type: Article

References (18)

1. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R (1993) Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49:440-447
2. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P (1994) Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18
3. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891
4. Hibbs RG, Corwin AL, Hassan NF, Kamel M, Darwish M, Edelman R, Constantine NT, Rao MR, Khalifa AS, Mokhtar S (1993) The epidemiology of antibody to hepatitis C in Egypt J Infect Dis 168:789-790
5. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD (1992) High HCV prevalence in Egyptian blood donors. Lancet 340:427
6. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32:884-892
7. Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, Abdel-Hamid M, Watts S, Fix AD, Strickland GT, Anwar W, Sallam I (2000) Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 63:236-241
8. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY (1997) New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35:201-207
9. Pybus OG, Rambaut A (2002) GENIE: Estimating demographic history from molecular phylogenies. Bioinformatics 18:1404-1405
10. Pybus OG, Rambaut A, Harvey PH (2000) An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155:1429-1437
11. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH (2001) The epidemic behavior of the hepatitis C virus. Science 292:2323-2325
12. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A (2003) The epidemiology and iatrogenic transmission of hepatitis C virus in egypt: a bayesian coalescent approach. Mol Biol Evol 20:381-387
13. Rao MR, Naficy AB, Schisterman E, Clemens JD, Edelman R, Darwish MA, Darwish NM (2002) Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis 2:29
14. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis 182:698-707
15. Stumpf MP, Pybus OG (2002) Genetic diversity and models of viral evolution for the hepatitis C virus. FEMS Microbiol Lett 214:143-152
16. Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, Tsukiyama-Kohara K, Kawaguchi R, Tanaka S, Kohara M (1999) Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116:636-642
17. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ (2002) Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 99:15584-15589
18. WHO (1993) The control of schistosomiasis: Second report of the WHO expert committee (WHO Technical Report Series 830). WHO, Geneva